Olema Pharmaceuticals, Inc. ($OLMA)
Filing Information
| Accession Number | 0001831216-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 15, 2026 |
| Document Date | Jan 12, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
310,000
Total Value
$3,594,229.17
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CH. DISCOV. & NON-CLIN DEV OFF | Common Stock | โ | Jan 12, 2026 | Sale | 10,000 | $28.34 | $283,400.00 | 144,846 | Indirect | See Footnote | View Details | |
CH. DISCOV. & NON-CLIN DEV OFF | Common Stock | โ | Jan 13, 2026 | Exercise/Conversion | 50,000 | $4.87 | $243,500.00 | 592,761 | Direct | โ | View Details | |
CH. DISCOV. & NON-CLIN DEV OFF | Common Stock | โ | Jan 13, 2026 | Sale | 49,800 | $27.60 | $1,374,480.00 | 542,961 | Direct | โ | View Details | |
CH. DISCOV. & NON-CLIN DEV OFF | Common Stock | โ | Jan 13, 2026 | Sale | 200 | $28.49 | $5,698.00 | 542,761 | Direct | โ | View Details | |
CH. DISCOV. & NON-CLIN DEV OFF | Common Stock | โ | Jan 14, 2026 | Exercise/Conversion | 50,000 | $4.87 | $243,500.00 | 592,761 | Direct | โ | View Details | |
CH. DISCOV. & NON-CLIN DEV OFF | Common Stock | โ | Jan 14, 2026 | Sale | 14,997 | $28.60 | $428,914.20 | 577,764 | Direct | โ | View Details | |
CH. DISCOV. & NON-CLIN DEV OFF | Common Stock | โ | Jan 14, 2026 | Sale | 35,003 | $28.99 | $1,014,736.97 | 542,761 | Direct | โ | View Details | |
CH. DISCOV. & NON-CLIN DEV OFF | Stock Option (Right to Buy) | Derivative | Jan 13, 2026 | Exercise/Conversion | 50,000 | $0.00 | $0.00 | 100,000 | Direct | โ | View Details | |
CH. DISCOV. & NON-CLIN DEV OFF | Stock Option (Right to Buy) | Derivative | Jan 14, 2026 | Exercise/Conversion | 50,000 | $0.00 | $0.00 | 50,000 | Direct | โ | View Details |